TVARDI THERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax
TVARDI THERAPEUTICS, INC. (TVRD) reported Other Comprehensive Income (Loss), Net of Tax of $260.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2025-05-13
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2024-09-30 was $96.00K, a 67.01% decline year-over-year.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2024-06-30 was $70.00K, a 81.13% decline year-over-year.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2024-03-31 was $69.00K, a 87.92% decline year-over-year.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2023-09-30 was $291.00K.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2024 was $260.00K, a 81.59% decline from fiscal 2023.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2023 was $1.41M.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$1.31M.
- TVARDI THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2021 was -$431.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2024-12-31 | $260.00K 10-K · filed 2025-03-11 | |||
| 2024-09-30 | $96.00K 10-Q · filed 2024-11-14 | $166.00K derived: sum of 2 quarters · filed 2024-11-14 | $235.00K derived: sum of 3 quarters · filed 2025-05-13 | |
| 2024-06-30 | $70.00K 10-Q · filed 2024-11-14 | $139.00K derived: sum of 2 quarters · filed 2025-05-13 | ||
| 2024-03-31 | $69.00K 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $1.41M 10-K · filed 2025-03-11 | |||
| 2023-09-30 | $291.00K 10-Q · filed 2024-11-14 | $662.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.23M derived: sum of 3 quarters · filed 2024-11-14 | |
| 2023-06-30 | $371.00K 10-Q · filed 2024-11-14 | $942.00K derived: sum of 2 quarters · filed 2024-11-14 | ||
| 2023-03-31 | $571.00K 10-Q · filed 2024-11-14 | |||
| 2022-12-31 | -$1.31M 10-K · filed 2025-03-11 | |||
| 2022-09-30 | -$101.00K 10-Q · filed 2023-11-13 | -$425.00K derived: sum of 2 quarters · filed 2023-11-13 | -$1.79M derived: sum of 3 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$324.00K 10-Q · filed 2023-11-13 | -$1.69M derived: sum of 2 quarters · filed 2023-11-13 | ||
| 2022-03-31 | -$1.36M 10-Q · filed 2023-11-13 | |||
| 2021-12-31 | -$431.00K 10-K · filed 2024-03-06 | |||
| 2021-09-30 | $6.00K 10-Q · filed 2022-11-07 | -$11.00K derived: sum of 2 quarters · filed 2022-11-07 | -$72.00K derived: sum of 3 quarters · filed 2022-11-07 | -$362.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | -$17.00K 10-Q · filed 2022-11-07 | -$78.00K derived: sum of 2 quarters · filed 2022-11-07 | -$368.00K derived: sum of 3 quarters · filed 2023-03-06 | -$640.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | -$61.00K 10-Q · filed 2022-11-07 | -$351.00K derived: sum of 2 quarters · filed 2023-03-06 | -$623.00K derived: sum of 3 quarters · filed 2023-03-06 | $80.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | -$290.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$562.00K derived: sum of 2 quarters · filed 2023-03-06 | $141.00K derived: sum of 3 quarters · filed 2023-03-06 | -$97.00K 10-K · filed 2023-03-06 |
| 2020-09-30 | -$272.00K 10-Q · filed 2021-11-08 | $431.00K derived: sum of 2 quarters · filed 2021-11-08 | $193.00K 10-Q · filed 2020-11-09 | $210.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $703.00K 10-Q · filed 2021-11-08 | $465.00K 10-Q · filed 2020-08-10 | $482.00K derived: sum of 3 quarters · filed 2022-03-01 | $470.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$238.00K 10-Q · filed 2021-11-08 | -$221.00K derived: sum of 2 quarters · filed 2022-03-01 | -$233.00K derived: sum of 3 quarters · filed 2022-03-01 | -$141.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $5.00K derived: sum of 2 quarters · filed 2022-03-01 | $97.00K derived: sum of 3 quarters · filed 2022-03-01 | $284.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$12.00K 10-Q · filed 2020-11-09 | $80.00K derived: sum of 2 quarters · filed 2020-11-09 | $267.00K 10-Q · filed 2020-11-09 | $140.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $92.00K 10-Q · filed 2020-11-09 | $279.00K 10-Q · filed 2020-08-10 | $152.00K derived: sum of 3 quarters · filed 2021-02-25 | $222.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $187.00K 10-Q · filed 2020-11-09 | $60.00K derived: sum of 2 quarters · filed 2021-02-25 | $130.00K derived: sum of 3 quarters · filed 2021-02-25 | $187.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$57.00K derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | -$44.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $70.00K 10-Q · filed 2019-11-05 | $127.00K derived: sum of 2 quarters · filed 2019-11-05 | $83.00K 10-Q · filed 2019-11-05 | -$27.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $57.00K 10-Q · filed 2019-11-05 | $13.00K 10-Q · filed 2019-08-07 | -$97.00K derived: sum of 3 quarters · filed 2020-02-27 | -$44.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$44.00K 10-Q · filed 2019-11-05 | -$154.00K derived: sum of 2 quarters · filed 2020-02-27 | -$101.00K derived: sum of 3 quarters · filed 2020-02-27 | -$138.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$57.00K derived: sum of 2 quarters · filed 2020-02-27 | -$94.00K derived: sum of 3 quarters · filed 2020-02-27 | -$73.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $16.00K derived: sum of 2 quarters · filed 2018-11-06 | $37.00K 10-Q · filed 2018-11-06 | $20.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$16.00K 10-Q · filed 2018-08-07 | -$33.00K derived: sum of 3 quarters · filed 2019-03-12 | -$54.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $21.00K 10-Q · filed 2018-05-09 | $4.00K derived: sum of 2 quarters · filed 2019-03-12 | -$17.00K derived: sum of 3 quarters · filed 2019-03-12 | $20.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$38.00K derived: sum of 2 quarters · filed 2019-03-12 | -$1.00K derived: sum of 3 quarters · filed 2019-03-12 | $38.00K 10-K · filed 2019-03-12 |
| 2016-09-30 | -$21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $16.00K derived: sum of 2 quarters · filed 2017-11-02 | $55.00K 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $76.00K 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $39.00K 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | -$35.00K 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |